Study guide
5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
Veterinary Technician Specialist in Emergency and Critical Care VTS ECC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment
1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions
2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR
2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism
3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance
3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders
4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation
4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics
5 Chapter 5: Gastrointestinal & Hepatic Emergencies
5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions
6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions
7 Chapter 7: Renal & Urinary Emergencies
7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation
8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS
8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies
9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles
10 Chapter 10: Neurological Emergencies
10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization
11 Chapter 11: Endocrine & Metabolic Crises
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
12 Chapter 12: Reproductive & Musculoskeletal Emergencies
12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation
13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20
13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist
5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
Key Takeaways Explain This Topic AI
Acute Liver Failure (ALF) results in acute loss of hepatic metabolic capacity, producing severe hypoglycemia, hypoalbuminemia, hyperammonemia, and coagulopathy.
Factor VII has the shortest half-life (4–6 hours) among clotting factors; consequently, Prothrombin Time (PT) prolongs earlier than aPTT in acute hepatic failure and vitamin K deficiency.
Hepatic Encephalopathy (HE) is driven by hyperammonemia crossing the blood-brain barrier, where astrocytic glutamine accumulation triggers cytotoxic cerebral edema and GABA-receptor up-regulation.
Medical management of HE centers on lactulose (acidifies colonic lumen to trap NH3 as non-absorbable NH4+) and levetiracetam for seizures; benzodiazepines are strictly contraindicated.
Biliary emergencies include gallbladder mucoceles (classic 'kiwi fruit' ultrasound pattern) and bile peritonitis, diagnosed when peritoneal fluid total bilirubin is >2x higher than serum bilirubin.
Last updated: August 2026
Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
The liver serves as the metabolic engine of the body, orchestrating carbohydrate homeostasis, albumin synthesis, coagulation factor production, and nitrogenous waste detoxification. When acute hepatocyte necrosis occurs—or when portal blood bypasses hepatic parenchyma via portosystemic shunts ( PSS )—the loss of these vital functions precipitates life-threatening systemic crises.
1. Critical Hepatic Functions & Acute Liver Failure (ALF)
Because the liver possesses immense functional reserve, clinical liver failure typically signifies the acute loss of >70% to 80% of functional hepatocyte mass.
Key Hepatic Functions in the ICU
Carbohydrate Metabolism: Hepatic gluconeogenesis and glycogenolysis maintain baseline blood glucose. Acute failure results in profound, refractory hypoglycemia .
Protein & Colloid Oncotic Synthesis: Hepatocytes synthesize almost all circulating plasma proteins, notably albumin (which accounts for 80% of plasma Colloid Oncotic Pressure [COP]). Hypoalbuminemia results in cavitary effusions (ascites) and peripheral edema.
Coagulation Factor Synthesis: The liver produces all coagulation factors except Factor VIII and von Willebrand factor (vWF). It uniquely synthesizes the Vitamin K-dependent factors: II, VII, IX, and X , as well as endogenous anticoagulants (Protein C, Protein S, Antithrombin III).
Nitrogen Detoxification (Urea Cycle): Ammonia ( N H 3 NH_3 N H 3 ), generated by enteric bacterial degradation of dietary proteins and amino acid deamination, is cleared from portal blood and converted to non-toxic, water-soluble urea.
Common Toxic & Infectious Etiologies of ALF
Etiological Category Specific Agents & Hepatotoxins Mechanism of Hepatocyte Injury
Dietary & Environmental Toxins Xylitol (artificial sweetener) Triggers massive endogenous insulin surge causing profound hypoglycemia, followed by acute fulminant hepatic necrosis.
Sago Palm ( Cycas revoluta ) Cycasin toxin causes acute centrilobular coagulative hepatic necrosis and severe coagulopathy.
Blue-Green Algae ( Microcystis ) Microcystin hepatotoxins inhibit protein phosphatases, disrupting hepatocyte cytoskeletons and causing intrahepatic hemorrhage.
Mushrooms ( Amanita phalloides ) Amatoxins inhibit RNA polymerase II, arresting cellular protein synthesis.
Pharmaceuticals Acetaminophen (Paracetamol) Saturated glucuronidation pathways lead to toxic NAPQI metabolite accumulation, depleting glutathione; causes methemoglobinemia and acute hepatic necrosis (especially in cats).
Idiosyncratic Reactions Carprofen, potentiated sulfonamides, phenobarbital, lomustine, methimazole.
Infectious Agents Leptospira interrogans Direct bacterial endothelial and hepatocyte injury, causing acute hepatitis, cholestasis, and concurrent AKI.
Canine Adenovirus-1 (CAV-1) Infectious Canine Hepatitis causing centrilobular necrosis and hepatic endothelial damage.
Loading diagram... Pathophysiology & Management of Hepatic Encephalopathy
2. Hepatic Encephalopathy (HE): Pathophysiology & Clinical Stages
Hepatic Encephalopathy (HE) is a complex neuropsychiatric syndrome resulting from the accumulation of gut-derived neurotoxins that enter the systemic circulation due to severe hepatic parenchymal dysfunction or congenital/acquired portosystemic shunts (PSS) .
The Ammonia–Glutamine Astrocyte Hypothesis
Hyperammonemia: Elevated systemic ammonia ( N H 3 NH_3 N H 3 ) readily crosses the blood-brain barrier into cerebral astrocytes.
Astrocyte Swelling: In the brain, astrocytes metabolize ammonia by combining it with glutamate via glutamine synthetase to form glutamine . Glutamine acts as a potent intracellular osmolyte, drawing free water into astrocytes and generating cytotoxic cerebral edema .
GABA/Benzodiazepine Up-Regulation: HE induces profound up-regulation of inhibitory γ \gamma γ -aminobutyric acid (GABA) and central benzodiazepine receptors, while increasing endogenous neurosteroids and false neurotransmitters (e.g., octopamine), depressing conscious central nervous system activity.
Clinical Staging of Hepatic Encephalopathy
Stage I (Mild): Subtle behavioral alterations, mild lethargy, sleep-wake cycle disturbances, restlessness, mild unresponsiveness to commands.
Stage II (Moderate): Pacing, mild ataxia, aimless wandering, head pressing , amaurosis (central cortical blindness with intact pupillary light reflexes), personality changes, and ptyalism/hypersalivation (especially in cats).
Stage III (Severe): Marked stupor, severe ataxia, pronounced vocalization, muscle tremors, hyperreflexia, responsive only to noxious stimuli.
Stage IV (Coma): Coma, unresponsiveness to deep pain, decerebrate posturing, generalized tonic-clonic seizures, and impending brainstem herniation.
3. Medical Management of Hepatic Encephalopathy
Emergency medical management aims to decrease the production and systemic absorption of enteric nitrogenous neurotoxins:
1. Lactulose Therapy
Mechanism of Action: Lactulose is a non-absorbable synthetic disaccharide (galactose-fructose). Colonic bacteria ferment lactulose into short-chain organic acids (lactic, acetic, and formic acids), dropping colonic pH below 5.0.
Ammonia Trapping: In an acidic lumen, free diffusible ammonia ( N H 3 NH_3 N H 3 ) is protonated into charged, non-diffusible ammonium ( N H 4 + NH_4^+ N H 4 + ) . Ammonium cannot cross colonic mucosal membranes and is trapped and evacuated in feces ( "ammonia trapping" ). Additionally, lactulose exerts an osmotic laxative effect, accelerating transit.
Dosing Goal: Administered PO or via retention enema (diluted 1:3 with warm water) titrated to achieve 2 to 3 soft, formed stools per day .
2. Enteric Antimicrobial Suppression
Targeting Urease-Producing Microbes: Administer antibiotics to suppress colonic bacteria that produce urease (the enzyme converting urea into ammonia):
Metronidazole: 7.5 to 10 mg/kg PO or IV q12h (use reduced dosing to prevent drug accumulation and neurotoxicity in patients with hepatic failure).
Neomycin: Non-absorbable aminoglycoside administered PO or via enema.
Rifaximin: Non-absorbable rifamycin derivative.
3. Critical Pharmacological Rules: Seizure Management
First-Line Anticonvulsant: Levetiracetam (Keppra) ( 20 to 30 mg/kg IV ) is the anticonvulsant of choice because it undergoes minimal hepatic metabolism (eliminated primarily via renal excretion) and does not bind GABA/benzodiazepine receptors.
Contraindication of Benzodiazepines: Diazepam and midazolam are strictly contraindicated in hepatic encephalopathy! Because endogenous benzodiazepine receptor tone is already pathologically elevated in HE, exogenous benzodiazepines will precipitate profound, prolonged coma. (Flumazenil can be administered to reverse benzodiazepine-induced HE exacerbations).
4. Coagulopathy of Acute Hepatic Failure
Coagulopathy is a hallmark of severe acute hepatic disease, developing through impaired factor synthesis, failure to clear activated clotting factors, and vitamin K malabsorption.
The Short Half-Life of Factor VII: Among the vitamin K-dependent factors (II, VII, IX, X), Factor VII possesses the shortest circulating half-life (only 4 to 6 hours) .
Diagnostic Discrepancy: Because Factor VII belongs exclusively to the Extrinsic Pathway , Prothrombin Time (PT) prolongs first, well before the Activated Partial Thromboplastin Time (aPTT / Intrinsic Pathway) becomes abnormal.
Therapeutic Interventions:
Vitamin K1 (Phytonadione): Administer 1.0 to 2.0 mg/kg SC or PO q12–24h using small-gauge needles to prevent hematoma formation ( never give IV due to lethal anaphylaxis risk ).
Fresh Frozen Plasma (FFP): Transfuse 10 to 20 mL/kg IV for patients with active cavitary hemorrhage or prior to invasive procedures (liver biopsy, abdominocentesis).
- 5. Critical Biliary Emergencies
- Gallbladder Mucocele
Pathophysiology: Cystic mucosal hyperplasia of the gallbladder wall accompanied by excessive secretion of thick, gelatinous, inspissated bile and mucus. Common in older Shetland Sheepdogs, Miniature Schnauzers, and Cocker Spaniels, often associated with hyperlipidemia, Cushing's disease, or hypothyroidism.
Ultrasound Hallmark: Pathognomonic "kiwi fruit" or stellate pattern (central organized hyperechoic mucus with radiating striations and an immotile, non-gravity-dependent lumen).
Complications: Ischemic gallbladder wall necrosis, rupture, and secondary bile peritonitis. Curative therapy requires emergency cholecystectomy .
Extrahepatic Biliary Obstruction (EHBO) & Bile Peritonitis
EHBO: Obstruction of the common bile duct by choleliths, pancreatitis, or mass lesions. Manifests with progressive hyperbilirubinemia, marked icterus, and acholic (clay-colored/white) feces due to absent stercobilin in the intestine.
Bile Peritonitis Diagnostic Criteria:
Chemical and secondary bacterial peritonitis resulting from bile leakage into the peritoneal cavity.
Definitive Diagnosis: Peritoneal fluid total bilirubin concentration is GREATER THAN 2 TIMES (>2x) the concurrent peripheral serum total bilirubin concentration .
Cytology: Green-brown/golden amorphous or crystal-like bile pigment engulfed by degenerate neutrophils.